Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Back to SCHOOL

SignaBlok’s Alexander Sigalov comments on SCHOOL peptide technology, revealing how this innovative approach can contribute significantly to the improvement of existing therapies for a range of malignancies and diseases.

Alexander Sigalov (September 2015)

Keywords: Intracellular signalling pathway, Transmembrane signal transduction, Intrinsically disordered proteins, Tumour-associated macrophages

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |